RIZZO, FEDERICA
RIZZO, FEDERICA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
A model for motor neuron degeneration and treatment of Spinal Muscular Atrophy using human induced pluripotent stem cells
2011 S. Corti, F. Magri, M. Nizzardo, C. Simone, M. Falcone, S. Salani, C. Donadoni, M. Nardini, G. Riboldi, G. Menozzi, C. Bonaglia, F. Rizzo, N. Bresolin, G. Comi
Animal Models of CMT2A: State-of-art and Therapeutic Implications
2020 R. De Gioia, G. Citterio, E. Abati, M. Nizzardo, N. Bresolin, G.P. Comi, S. Corti, F. Rizzo
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
2014 F. Rizzo, G. Riboldi, S. Salani, M. Nizzardo, C. Simone, S. Corti, E. Hedlund
Clinical and genetic features of a cohort of patients with MFN2-related neuropathy
2022 E. Abati, A. Manini, D. Velardo, R. Del Bo, L. Napoli, F. Rizzo, M. Moggio, N. Bresolin, E. Bellone, M.T. Bassi, M.G. D'Angelo, G.P. Comi, S. Corti
Development of a therapeutic approach for Spinal Muscular Atrophy with Respiratory Distress (SMARD1) using human induced pluripotent stem cell-derived neural stem cells and motor neurons
2013 S. C. Nizzardo M., F. Rizzo, M. Ruggieri, S. Salani, . Brajkovics, N. Bresolin, S. Corti
Direct reprogramming of human astrocytes into neural stem cells and neurons
2012 S. Corti, M. Nizzardo, C. Simone, M. Falcone, C. Donadoni, S. Salani, F. Rizzo, M. Nardini, G. Riboldi, F. Magri, C. Zanetta, I. Faravelli, N. Bresolin, G.P. Comi
Disease Modeling and Therapeutic Strategies in CMT2A: State of the Art
2019 K. Barbullushi, E. Abati, F. Rizzo, N. Bresolin, G.P. Comi, S. Corti
Downregulation of glutamic acid decarboxylase in Drosophila TDP- 43-null brains provokes paralysis by affecting the organization of the neuromuscular synapses
2018 G. Romano, N. Holodkov, R. Klima, F. Grilli, C. Guarnaccia, M. Nizzardo, F. Rizzo, R. Garcia, F. Feiguin
Effect of combined systemic and local morpholino treatment on the spinal muscular atrophy δ7 mouse model phenotype
2014 M. Nizzardo, C. Simone, S. Salani, M. Ruepp, F. Rizzo, M. Ruggieri, C. Zanetta, S. Brajkovic, H.M. Moulton, O. Müehlemann, N. Bresolin, G.P. Comi, S. Corti
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model
2015 M. Nizzardo, C. Simone, F. Rizzo, S. Salani, P. Rinchetti, R. Del Bo, S. Dametti, K. Foust, B. Kaspar, N. Bresolin, G. Comi, S. Corti
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model
2015 M. Nizzardo, C. Simone, F. Rizzo, S. Salani, S. Dametti, P. Rinchetti, R. Del Bo, K. Foust, B.K. Kaspar, N. Bresolin, G.P. Comi, S. Corti
Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies
2012 S. Salani, C. Donadoni, F. Rizzo, N. Bresolin, G.P. Comi, S. Corti
GENERAZIONE DI IPSC COME MODELLO IN VITRO E SVILUPPO DI UN POSSIBILE APPROCCIO TERAPEUTICO PER LA MALATTIA DI CHARCHOT-MARIE-TOOTH DI TIPO 2A(CMT2A)
2015 F. Rizzo
Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy
2012 S. Corti, M. Nizzardo, C. Simone, M. Falcone, M. Nardini, D. Ronchi, C. Donadoni, S. Salani, G. Riboldi, F. Magri, G. Menozzi, C. Bonaglia, F. Rizzo, N. Bresolin, G.P. Comi
Genetic correction of spinal muscular atrophy-induced pluripotent stem cells and motoneurons as a disease model and cell source for transplantation
2012 G. Riboldi, M. Nizzardo, M. Nardini, C. Simone, M. Falcone, D. Ronchi, C. Donadoni, S. Salani, F. Magri, F. Rizzo, M. Ranieri, A. Govoni, I. Faravelli, C. Zanetta, N. Bresolin, G.P. Comi, S. Corti
Genome-wide RNA-seq and proteomic analysis of motor neurons indicates selective cytoskeletal perturbation in Brown-Vialetto disease, partially rescued by riboflavin
2017 F. Rizzo, A. Ramirez, C. Compagnucci, S. Salani, V. Melzi, A. Bordoni, F. Fortunato, N. Bresolin, G.P. Comi, E. Bertini, M. Nizzardo, S. Corti
IPSC-derived neural stem cells act via kinase inhibition to exert neuroprotective effects in spinal muscular atrophy with respiratory distress type 1
2014 C. Simone, M. Nizzardo, F. Rizzo, M. Ruggieri, G. Riboldi, S. Salani, M. Bucchia, N. Bresolin, G.P. Comi, S. Corti
Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons
2019 F. Rizzo, M. Nizzardo, S. Vashisht, E. Molteni, V. Melzi, M. Taiana, S. Salani, P. Santonicola, E. Di Schiavi, M. Bucchia, A. Bordoni, I. Faravelli, N. Bresolin, G.P. Comi, U. Pozzoli, S. Corti
MFN2-related neuropathies: clinical features, molecular pathogenesis and therapeutic perspectives
2015 G. Stuppia, F. Rizzo, G. Riboldi, R. Del Bo, M. Nizzardo, C. Simone, G.P. Comi, N. Bresolin, S. Corti
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model
2014 M. Nizzardo, C. Simone, F. Rizzo, M. Ruggieri, S. Salani, G. Riboldi, I. Faravelli, C. Zanetta, N. Bresolin, G.P. Comi, S. Corti